Digital Assets & Virtual Assets
RWA Tokenisation in Hong Kong: Legal Framework and Structuring Guide
Technology licensing is the mechanism by which intellectual property rights in technology — software, patents, trade secrets, know-how, or proprietary data — are granted to another party for use, typically in exchange for royalties or other consideration. As Hong Kong grows as a technology and innovation hub, technology licensing agreements are increasingly central to commercial transactions across sectors including fintech, health tech, data services, and professional services.
An exclusive licence grants the licensee the sole right to use the licensed technology, typically within a defined field of use, territory, or time period. Even the licensor may be excluded from using the technology within the scope of the exclusivity. Exclusive licences are valuable and command higher royalties; they may also carry obligations on the licensee to actively exploit the licence (use-it-or-lose-it provisions).
A non-exclusive licence allows the licensor to grant the same rights to multiple licensees simultaneously. This is the most common form for software licensing (e.g., commercial SaaS or enterprise software licences) and for licensing technology that the licensor wishes to monetise broadly.
A sole licence is exclusive in the sense that the licensor will not grant the same licence to others, but the licensor itself retains the right to use the technology. This is a middle ground between exclusive and non-exclusive licensing.
Precision in defining the licensed rights is critical. The agreement should clearly specify:
Royalty structures vary widely:
Audit rights — allowing the licensor to verify the licensee's royalty calculations — are standard in royalty-bearing licence agreements. The frequency, notice requirements, and cost allocation for audits should be negotiated.
A key commercial issue in technology licensing is who owns improvements or derivative works made by the licensee. Possible approaches include:
Licensors typically warrant that they have the right to grant the licence, that the licensed technology does not infringe third-party IP rights, and (for software) that it performs materially in accordance with its documentation. The scope of warranties is heavily negotiated: licensors of mature technologies are generally willing to make stronger warranties; those licensing early-stage or experimental technology often limit warranties significantly.
Technology licences almost universally include liability caps (typically limiting liability to the value of fees paid in the preceding 12 months) and mutual exclusions of consequential, indirect, and special damages. The carve-outs from caps — commonly including death and personal injury, fraud, and IP indemnities — require careful negotiation.
Clear termination triggers (material breach, insolvency, change of control) and post-termination obligations (cessation of use, return or destruction of materials, transition assistance) are essential. For software licences, data portability and migration support on termination are increasingly important commercial considerations.
Alan Wong LLP's corporate and commercial team advises technology companies, startups, corporate licensees, and investors on the full range of technology licensing arrangements. We draft and negotiate licensing agreements, advise on IP ownership and assignment structures, and assist with licensing disputes. Our team has experience across software licensing, SaaS agreements, patent licensing, data licensing, and AI model licensing arrangements in the Hong Kong and regional context.
Hong Kong permanent residents who hold foreign nationality face complex succession planning considerations spanning multiple legal systems. This article examines the key legal issues, including applicable succession law, forced heirship, and cross-border estate planning strategies.
Mergers and acquisitions involving Hong Kong listed companies are governed by the Takeovers Code administered by the SFC. This article examines the key rules on mandatory offers, whitewash waivers, regulatory approvals, and the timetable for public M&A transactions in Hong Kong.